% | $
Quotes you view appear here for quick access.

công ty Questcor Pharmaceuticals Message Board

  • jonzkelleeyzprofessionalbasher jonzkelleeyzprofessionalbasher Dec 6, 2012 12:52 PM Flag

    Questcor Update: Largest Privately Owned Pharmacy Benefits Manager Study Finds 96% of Acthar Prescriptions Unnecessary

    Another Step Towards Questcor's Inevitable Endgame

    Today, Citron shares a new key data point, so far overlooked by Wall Street. This one is from Prime Therapeutics, the largest privately-held PBM in the United States, as well as a thought leader in pharmacy benefit management strategies. Their partnership with Blue Cross and Blue Shield covers 20 million people nationwide with an annual drug spend of $12.4 billion. Prime recently issued a case study summary with regard to Acthar Gel prescriptions. Its write-up of a study of 30 Acthar prescriptions states : "Analysis Finds 96% of Use Unnecessary".

    This aligns Prime with Aetna's increasingly restrictive coverage policies on Acthar, disclosed just a few weeks ago.